| abstract |
Provided herein are novel molecular markers and targets of liver disease, including NAFLD, NASH, liver fibrosis and related conditions. Also provided herein are methods of screening for modulators of such molecular markers and targets for the treatment of diseases of the liver as well as the modulators useful for treating such disease. Also provided are novel molecular markers useful for diagnosing diseases of the liver, including, NAFLD, NASH, liver fibrosis and related conditions, and for monitoring the progression and treatment of such disease of the liver. |